Skip to content
Main Menu
  • Excelsior
    • About Excelsior Medical
    • Enterprise Spirit
    • Development Strategy
    • Related Company
    • Overseas Business
    • Company History
  • Product Description
    • Hemodialysis / Plasma Exchange
    • Blood Bag
    • Artificial Stoma
    • Health Appliances
  • ESG
  • Investors
  • Enterprise Recruitment
  • Contact Us

Monthly Sales-2025.05

 

Item Net Revenue
2025.05 707,008
2024.05 736,948
MoM Change -29,940
MoM Change (%) -4.06
2025 1-5 3,544,417
2024 1-5 3,475,803
YoY Change 68,614
YoY Change (%) 1.97
Note

 

PrevPREVIOUSAnnouncement on the expiry of members of the 5th term Remuneration Committee.
NEXTThe Company is invited to attend an institutional investor conference hosted by President Securities on May 28, 2025.Next

Investors

Material Information
Board of Directors
Corporate Governance
Organization
Major Internal Policies
Corporate Governance
Committee
Audit Committee
Remuneration Committee
Financial Information
Monthly Revenue
Financial Statements
Shareholder Services
Shareholders' Meeting
Institutional Investor Conference
Dividend
Stock Quotes
Stock Transfer Agent and Registrar
Contacts
Stakeholders
Investors
Main Menu
  • Excelsior
    • About Excelsior Medical
    • Enterprise Spirit
    • Development Strategy
    • Related Company
    • Overseas Business
    • Company History
  • Product Description
    • Hemodialysis / Plasma Exchange
    • Blood Bag
    • Artificial Stoma
    • Health Appliances
  • ESG
  • Investors
  • Enterprise Recruitment
  • Contact Us
  • 17F., No. 880, Zhongzheng Rd., Zhonghe Dist., New Taipei City, Taiwan
  • +886-2-2225-1888
[raiseup_copyright]